Specialist doctors will be able to prescribe patients cannabis-based medicines later this year, the government has revealed.
The decision to relax the rules around medicinal cannabis will help patients with an exceptional clinical need, said Home Secretary Sajid Javid.
Government departments will now work to define exactly what constitutes a ‘cannabis-derived medical product’, as only products meeting that definition will be available on prescriptions.
Sativa Investments (LON:SATI) seeks to invest in companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest.